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Phased‑array combination 
of 2D MRS for lipid composition 
quantification in patients 
with breast cancer
Vasiliki Mallikourti1*, Sai Man Cheung1, Tanja Gagliardi1,2, Nicholas Senn1, Yazan Masannat3, 
Trevor McGoldrick4, Ravi Sharma4, Steven D. Heys1,3,5 & Jiabao He1,5
Lipid composition in breast cancer, a central marker of disease progression, can be non‑invasively 
quantified using 2D MRS method of double quantum filtered correlation spectroscopy (DQF‑COSY). 
The low signal to noise ratio (SNR), arising from signal retention of only 25% and depleted lipids within 
tumour, demands improvement approaches beyond signal averaging for clinically viable applications. 
We therefore adapted and examined combination algorithms, designed for 1D MRS, for 2D MRS with 
both internal and external references. Lipid composition spectra were acquired from 17 breast tumour 
specimens, 15 healthy female volunteers and 25 patients with breast cancer on a clinical 3 T MRI 
scanner. Whitened singular value decomposition (WSVD) with internal reference yielded maximal SNR 
with an improvement of 53.3% (40.3–106.9%) in specimens, 84.4 ± 40.6% in volunteers, 96.9 ± 54.2% 
in peritumoural adipose tissue and 52.4% (25.1–108.0%) in tumours in vivo. Non‑uniformity, as 
variance of improvement across peaks, was low at 21.1% (13.7–28.1%) in specimens, 5.5% (4.2–7.2%) 
in volunteers, 6.1% (5.0–9.0%) in peritumoural tissue, and 20.7% (17.4–31.7%) in tumours in vivo. The 
bias (slope) in improvement ranged from − 1.08 to 0.21%/ppm along the diagonal directions. WSVD 
is therefore the optimal algorithm for lipid composition spectra with highest SNR uniformly across 
peaks, reducing acquisition time by up to 70% in patients, enabling clinical applications.
Lipid composition is a central marker for the pathogenesis of breast  cancer1, 2, the most commonly diagnosed can-
cer among  women3. Conventional magnetic resonance spectroscopy (MRS) of stimulated echo acquisition mode 
(STEAM) with short echo time can detect lipid spectral peaks in the breast non-invasively on standard clinical 
 scanners4, and further enhancement in specificity is valuable for clinical applications. Spectral editing methods 
of double quantum filtering (DQF), effectively suppress background signals, but only target a single metabolite, 
such as polyunsaturated fatty acids (PUFA) in 1D  MRS5. The two dimensional (2D) MRS method of correlation 
spectroscopy (COSY)6 resolves lipid composition on a 2D map, but suffers from the dominant water signal and 
wide peak  spread7. DQF-COSY, combining the strength of spectral editing and 2D MRS, allows unobscured 
identification of individual lipid resonances through sharp peak appearance and suppression of water contamina-
tion  signals8. However, both the signal retention of only 25% in DQF-COSY7 and depleted lipids within breast 
 tumours59 contribute to low signal to noise ratio (SNR), posing a challenge for accurate quantification. Since 
DQF-COSY collects a series of 1D spectra demanding a long acquisition time (typical scan time of 15–20 min)10, 
SNR improvement approaches beyond signal averaging are required for clinically viable applications.
Phased-array coils have been widely adopted in routine clinical practice, with signal combination algo-
rithms developed to enhance SNR and reduce acquisition  time11,12. Adaptively Optimised Combination (AOC)13, 
amongst current combination algorithms developed for 1D MRS (Table 1)13–16, is the optimal approach for 
spectra acquired in the brain using conventional  MRS13 and PUFA spectra acquired in the breast using spectral 
editing  MRS17. The SNR of a single spectral peak has been adopted as the common assessment criteria in the 
comparison of combination algorithms. However, lipid composition in 2D MRS is determined utilising multiple 
spectral peaks across the 2D map, demanding an algorithm with uniform improvement. In contrast to spectral 
editing MRS, DQF-COSY retains the presence of dominant metabolites, at reduced amplitude, for the estimation 
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of sensitivities and phases of coil elements, potentially eliminating the need to acquire an additional reference 
spectrum.
We hypothesise that AOC is the optimal algorithm to provide maximal SNR improvement uniformly across 
the 2D lipid composition spectrum in breast cancer. We therefore adapted current algorithms (Table 1), with 
a particular focus on noise decorrelated algorithms, for 2D MRS and applied on lipid composition spectra 
acquired using DQF-COSY. The combination algorithms were evaluated on spectra acquired from breast tumour 
specimens, healthy female volunteers and patients with breast cancer, with data from the tumour and the peri-
tumoural adipose tissue (Fig. 1a). Each algorithm was implemented twice with weighting coefficients derived 
from the spectrum without water suppression (external reference, denoted by subscript “e”) and first signal of 
the DQF-COSY acquisition (internal reference, denoted by subscript “i”) (Fig. 1b). The non-uniformity of SNR 
improvement across spectral peaks (Table 2) and the direction of non-uniformity was additionally evaluated. 
The non-uniformity was defined as the coefficient of variance of SNR improvement across spectral peaks. The 
direction of non-uniformity was quantified as the slopes along the diagonal (bias along the frequency axes) and 
the off-diagonal (bias along the encoding axes) on a plane regressed to the SNR improvement at the spectral 
location of each peak.
Results
SNR among algorithms. For tumour specimens, the SNR from  WSVDi (median 81.9, interquartile 
range 57.2–136.4) was comparable against  WSVDe, but significantly higher than the other approaches (Table 3, 
Fig.  2a). For healthy volunteers,  WSVDi yielded the highest SNR (833.6 ± 308.6) with statistical significance 
(Table 3, Fig. 2b). For peritumoural adipose tissue in patients, the SNR from  WSVDi (584.6 ± 294.7) was com-
Table 1.  Summary of signal combination algorithms designed for 1D MRS. AOC adaptively optimised 
combination, CV coefficient of variance, nd-comb noise decorrelated combination, PCA Principal Component 
Analysis, WSVD whitened singular value decomposition.
Algorithms Description
Equal weighting Adding after aligning in phase
Signal weighting Aligning in phase and weighting with the signal of reference peak
S/N weighting Aligning in phase and weighting with the SNR of reference peak
S/N2 weighting Aligning in phase and weighting with the signal to the noise squared (S/N2) of reference peak
nd-comb Noise decorrelation using PCA, then aligning in phase and weighting the noise decorrelated data using the SNR of refer-ence peak
WSVD Noise decorrelation using PCA, then aligning in phase and weighting the noise decorrelated spectra using the first left singular vector obtained from the singular value decomposition of the noise decorrelated spectra
AOC Phasing and weighting with the signal of reference peak multiplied by the inverted noise correlation matrix
Weighting/phasing all signals
at each corresponding coil element
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Figure 1.  Diagram of study design and data processing. (a) Study design. Combination algorithms were 
evaluated on DQF-COSY spectra acquired from ex vivo and in vivo experiments by comparing the SNR. 
(b) Processing steps. Combination algorithms were applied on DQF-COSY spectra after signal averaging, 
apodisation and zero filling. AOC = adaptively optimised combination, nd-comb = noise decorrelated 
combination, WSVD = whitened singular value decomposition.
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parable against  AOCe, but significantly higher than the other approaches (Table 3, Fig. 2c). For tumours in vivo, 
the SNR from  WSVDi (49.8, 32.6–102.8) was significantly higher (p = 0.028) than nd-combi (43.1, 27.5–99.3), 
but comparable against other approaches (Table 3, Fig. 2d). Linear algorithms gave lower SNR compared with 
the noise decorrelated algorithms, and are presented only for information purposes (Table 3).  WSVDi improved 
the SNR by 53.3% (40.3–106.9%) in specimens, 84.4 ± 40.6% in volunteers, 96.9 ± 54.2% in peritumoural adipose 
tissue and 52.4% (25.1–108.0%) in tumours in vivo, reducing the acquisition time by 50–70% in tumour and 
adipose tissue respectively. The combined 2D spectra using  WSVDi from a specimen, volunteer, peritumoural 
tissue, and tumour in vivo are shown in Fig. 3.  
Non‑uniformity of SNR improvement across spectrum. For tumour specimens,  WSVDi had sig-
nificantly the lowest non-uniformity (21.1%, 13.7–28.1%, p < 0.05) (Table 4, Fig. 4a), with higher improvement 
towards low frequencies along diagonal direction (slope of − 3.79%/ppm) and mixing encoding  (t1/F1) along 
off-diagonal direction (slope of 4.90%/ppm) (Table 4, Fig. 5a,b). For healthy volunteers,  WSVDi had significantly 
lower non-uniformity (5.5%, 4.2–7.2%) compared against nd-combi (6.6%, 4.6–12.9%, p < 0.001), but no signifi-
cant differences against the other algorithms (Table 4, Fig. 4b). Higher improvement was found towards high fre-
quencies along diagonal direction (slope of 0.21%/ppm) and reading encoding  (t2/F2) along off-diagonal direc-
tion (slope of − 0.18%/ppm) (Table 4, Fig. 5a,c). For peritumoural adipose tissue,  WSVDi had significantly lower 
Table 2.  Peaks in 2D DQF-COSY spectra from breast.
Spectral peaks Locations  (F2,  F1) (ppm)
Methyl protons (0.9, 0.9)
Methylene protons (1.3, 1.3)
Methylene protons β to COO (1.6, 1.6)
Allylic methylene protons (2.1, 2.1)
Methylene protons α to COO (2.4, 2.4)
Diallylic methylene protons (2.8, 2.8)
Glycerol methylene protons (4.3, 4.3)
Olefinic protons (5.3, 5.3)
Unsaturated fatty acid cross peak (5.3, 2.8)
Unsaturated fatty acid cross peak (5.3, 2.1)
Unsaturated fatty acid cross peak (2.8, 5.3)
Unsaturated fatty acid cross peak (2.1, 5.3)
Table 3.  SNR of (1.3, 1.3) ppm in 2D lipid composition spectra using DQF-COSY. The median SNR and 
interquartile range are shown for non-normally distributed data while mean and standard deviation are shown 
for normally distributed data. P-value represents the comparison on SNR between the noise decorrelated 
algorithms using repeated measures ANOVA or Wilcoxon signed-rank tests. The SNR of the linear algorithms 
is also reported for reference purposes. Results are presented with  WSVDi as a reference for comparison. 
AOC adaptively optimised combination, CV coefficient of variance, nd-comb noise decorrelated combination, 




(N = 17) P-value
Healthy 
volunteers









(N = 10) P-value
External refer-
ence
Equal 59.5 (41.6–105.8) 469.5 ± 127.7 309.9 ± 112.5 37.8 (19.7–57.0)
Signal 75.4 (52.3–131.3) 621.4 ± 239.6 444.6 ± 215.9 42.9 (25.8–81.0)
S/N 76.9 (53.2–133.0) 637.4 ± 235.2 462.2 ± 219.2 46.1 (25.2–82.4)
S/N2 78.2 (53.3–133.4) 645.0 ± 229.1 472.4 ± 218.4 47.7 (24.8–81.9)
WSVD 82.3 (56.8–133.1) 0.246 825.6 ± 304.5 0.003 581.1 ± 291.6 0.022 50.5 (31.8–101.9) 0.241
nd-comb 82.4 (56.7–133.8) 0.049 812.1 ± 300.7  < 0.001 570.7 ± 291.0  < 0.001 48.5 (33.4–100.4) 0.575
AOC 82.5 (56.8–133.9) 0.003 825.7 ± 305.2 0.003 582.2 ± 293.2 0.100 50.2 (33.4–101.3) 0.575
Internal refer-
ence
Equal 39.5 (30.8–103.9) 457.4 ± 148.4 311.4 ± 154.6 37.4 (18.2–57.0)
Signal 54.1 (41.0–129.9) 609.8 ± 248.5 433.2 ± 230.8 41.2 (23.9–82.9)
S/N 57.5 (41.9–131.8) 624.9 ± 244.5 449.2 ± 237.2 43.6 (24.4–82.5)
S/N2 60.0 (41.6–132.2) 630.0 ± 240.4 482.5 ± 239.1 44.9 (24.6–81.4)
WSVD 81.9 (57.2–136.4) – 833.6 ± 308.6 – 584.6 ± 294.7 – 49.8 (32.6–102.8) –
nd-comb 64.2 (50.6–135.2)  < 0.001 743.6 ± 319.8 0.001 543.6 ± 310.7 0.007 43.1 (27.5–99.3) 0.028
AOC 60.0 (46.1–130.8)  < 0.001 781.4 ± 338.1 0.005 552.6 ± 312.9 0.034 46.0 (28.6–98.9) 0.059
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non-uniformity (6.1%, 5.0–9.0%) than  AOCi (8.2%, 5.6–10.7%), nd-combi (7.9%, 6.4–11.4%) and nd-combe 
(8.3%, 6.9–9.9%), but no significant difference from the other algorithms (Table 4, Fig. 4c). Higher improvement 
was found towards low frequencies along diagonal direction (slope of − 1.08%/ppm) and reading encoding  (t2/
F2) along off-diagonal direction (slope of − 0.30%/ppm) (Table 4, Fig. 5a,d). For tumours in vivo, there were 
no significant differences in non-uniformity from  WSVDi (20.7%, 17.4–31.7%) against the other algorithms 
(Table 4, Fig. 4d), with higher improvement towards low frequencies along diagonal direction (slope of − 1.1%/
ppm) and mixing encoding  (t1/F1) along off-diagonal direction (slope of 2.68%/ppm) (Table 4, Fig. 5a,e).  
Discussion
In this work, current combination algorithms, designed for 1D MRS, were adapted and evaluated for lipid com-
position spectra from breast acquired using 2D MRS, with a particular focus on noise decorrelation algorithms. 
 WSVDi was identified as the most effective signal combination approach in 2D MRS, instead of AOC, the opti-
mal algorithm for 1D  MRS13,17.  WSVDi provided maximal SNR improvement in patients (97% in peritumoural 
adipose tissue, 52% in tumour) and low non-uniformity of 6% and 21% respectively.  WSVDi, eliminating the 
need for acquiring an additional reference spectrum (typically scan time of 2 min), reduces scan time by 50–70% 
from 17 to 8 min in tumour and 5 min in peritumoural adipose tissue.
Noise decorrelation algorithms outperformed all linear algorithms substantially through the cancellation of 
correlated noise, as found in 1D MRS  studies13,17. WSVD performance was not degraded in low SNR spectra 
acquired from the tumours, in contrast to 1D spectra reported in previous  studies17,18. In high SNR spectra 
from adipose tissue, WSVD and AOC yielded comparable SNR and outperformed nd-comb, as observed in 1D 
PUFA  spectra17. Among the linear algorithms, S/N2 Weighting had the best SNR performance, in line with the 
1D MRS  studies14,17.
External reference methods  (WSVDe,  AOCe and nd-combe) showed comparable SNR ex vivo, with the perfor-
mance of nd-combe degraded in vivo due to the larger variation in coil weightings associated with the voxel loca-
tion away from the  isocentre14,15,19. For internal reference,  WSVDi outperformed  AOCi and nd-combi. External 
reference, with higher SNR than internal reference, is expected to provide more accurate weighting coefficients 
and in turn higher SNR of combined  spectra20, as observed in AOC and nd-comb. However, WSVD is less sensi-
tive to the SNR of the reference spectrum as observed in this work, with weighting coefficients generated from 
the entire  spectrum16 instead of a dominant peak, as in  AOC13 and nd-comb15.
WSVDi, in addition to providing maximal SNR, eliminates the need for the acquisition of a reference spec-
trum, reducing scan time by approximately 2 min.  WSVDi improved the SNR by 97% in peritumoural adipose 
Figure 2.  Comparison of the combination algorithms on DQF-COSY spectra using external and internal 
references. SNR of DQF-COSY spectra from (a) breast tumour specimens, (b) healthy volunteers, (c) 
peritumoural adipose tissue, and (d) tumours in vivo, using AOC, nd-comb, and WSVD. Median and 
interquartile range are shown for non-normally distributed data while mean and standard deviation are shown 
for normally distributed data. External and internal references were derived from the unsuppressed water 
spectrum and the spectrum of first signal (increment) in DQF-COSY respectively.
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tissue and 52% in tumours in vivo, allowing the acquisition of a lipid composition spectrum in less than 8 min 
in patients instead of 17 min (15 min for lipid composition spectrum and 2 min for reference spectrum).
WSVDe and  WSVDi showed better or comparable non-uniformity against other external and internal refer-
ence algorithms, with similar performance between  WSVDe and  WSVDi.  WSVDi had non-uniformity of 21% in 
specimens, 5% in volunteers, 6% in peritumoural adipose tissue and 21% in tumours in vivo, with the variation 
in non-uniformity reflecting the effects of noise on SNR improvement. The slope along the diagonals further 
confirmed the observation of non-uniformity, as higher slope (bias in SNR improvement) was associated with 
lower SNR (observed in spectra from tumours) and lower slope was associated with higher SNR (observed in 
spectra from adipose tissue). The magnitude of the slop was small in adipose tissue (0.21%/ppm and 0.18%/
ppm in healthy volunteers and 1.08%/ppm and 0.30%/ppm in peritumoural adipose tissue), indicating negligible 
changes of SNR improvement of 0.92% and 0.79% in healthy volunteers and 4.8% and 1.32% in peritumoural 
adipose tissue at a maximal frequency gap between peaks of interest (0.9 ppm to 5.3 ppm). However, the slopes 
found in tumours were noticeably higher with higher improvement towards low frequencies and mixing encod-
ing directions, likely due to the signal elevation closer to contamination water signal stripe along the mixing 
encoding direction (Fig. 3d). Hence,  WSVDi provides minimal non-uniformity for SNR improvement across 
lipid composition spectra.
Figure 3.  DQF-COSY combined spectra. DQF-COSY combined spectra using  WSVDi from (a) a specimen of 
invasive carcinoma, grade III, (b) the left breast of a healthy volunteer, (c) peritumoural adipose tissue from a 
patient with invasive carcinoma, grade III, and (d) an invasive carcinoma, grade III from a patient.
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DQF-COSY8, similar to  STEAM21, is composed of three 90° RF pulses, allowing a short echo time and a 
minimal chemical shift displacement. DQF-COSY, different from STEAM, modulates the evolution time t1 for 
2D spectral encoding and incorporates quantum coherence pathway selection gradients to suppress background 
signal, allowing enhanced specificity at the expense of a portion of  SNR8. DQF-COSY directly resolves mono-
unsaturated fatty acids (MUFA) and PUFA through J-coupling  sensitivity8, while STEAM instead demands a 
mathematical  model22. All lipid peaks could be well detected using conventional 1D MRS under reasonable 
water  suppression23, while DQF-COSY may have a big advantage for the detection of lipid peaks at 4.1 ppm and 
4.25 ppm under challenging conditions for water suppression. Hence, DQF-COSY, supported by its intrinsic 
minimal chemical shift displacement, high specificity and SNR enhancement from a phased-array combination 
approach may help studying small lesions or area of interest.
The extensive experiments on ex vivo tumour specimens, healthy participants and patients (over 70 datasets 
from clinical population) encompassed a wide range of physiological environments encountered in a clinical 
setting. The acquisition voxel was adjusted to the size of the tumour in diseased breast and standardised to 2 × 2 
× 2  cm3 in healthy breast, allowing investigation in both low and high SNR conditions. The comparison among 
algorithms was comprehensive, covering both internal and external references, with outcome measures extended 
beyond conventional SNR to non-uniformity. Both standard clinical hardware (scanner and coil) and routine 
patient imaging procedures were adopted to ensure the immediate clinical translation of the research findings. 
This study was limited to a single scanner and two different coils, and multi-centre studies on scanners and coils 
from a range of vendors are required before wider clinical adoption. Patients with invasive breast carcinoma were 
studied in this work to reduce the confounding factor of experimental setup, however larger patient cohorts with 
other phenotypes of breast cancer should be investigated in the future.
WSVD, the most effective combination algorithm for 2D MRS, can enhance the sensitivity of inconspicu-
ous lipid constituents found in tumours and accelerate the acquisition in adipose tissue. The extension of single 
voxel 2D MRS into chemical shift imaging (CSI) of 2D MRS allows the investigation of spatial distribution of 
lipid composition in tumour but is limited by the voxel size and a demanding acquisition time proportional to 
the number of voxels acquired. WSVD can potentially allow smaller voxel sizes and reduce acquisition time 
through trading the enhanced SNR, allowing the investigation of spatially heterogeneous response to neoadjuvant 
chemotherapy in breast  cancer24. CSI of 2D MRS, with further support from compressed sensing, can achieve 
direct lipid composition mapping of the entire breast, for the early detection and prevention of breast cancer, 
without the need of a mathematical model of lipid amplitudes based on the empirical assumptions made in the 
Dixon  method25. However, further investigation is needed to consider the spatial variability in the coil sensitivity 
and the combination of WSVD with compressed sensing for CSI of 2D MRS.
In conclusion,  WSVDi, instead of AOC, is the optimal approach for processing lipid composition spec-
tra acquired using 2D MRS on phased-array coils from the breast.  WSVDi not only provides maximal SNR 
Table 4.  Non-uniformity of SNR improvement in 2D lipid composition spectra using DQF-COSY. Data 
for CV are medians (interquartile range). Slope along the diagonal is positive from (0.9, 0.9) ppm to (5.3, 
5.3) ppm. Slope along the off diagonal is positive from reading  t2/F2 at (0.9, 5.3) ppm to mixing  t1/F1 at (5.3, 
0.9) ppm. P-value represents the comparison on CV values between the noise decorrelated algorithms using 
Wilcoxon signed-rank tests. Results are presented with  WSVDi as a reference for comparison. Data with 
negative SNR improvement were excluded (1 dataset from a healthy volunteer using  AOCi, 1 dataset from a 
healthy volunteer using nd-combi, and 1 dataset from a tumour in patients using nd-combi). AOC = adaptively 
optimised combination, CV = coefficient of variance, nd-comb = noise decorrelated combination, 
WSVD = whitened singular value decomposition.
Algorithms
Tumour specimens (N = 17)
Healthy volunteers
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Figure 4.  Comparison of non-uniformity of SNR improvement across the 2D spectrum in DQF-COSY. The 
non-uniformity of SNR improvement using the noise decorrelated algorithms of AOC, nd-comb, and WSVD is 
shown for DQF-COSY spectra in (a) breast tumour specimens, (b) healthy volunteers, (c) peritumoural adipose 
tissue, and (d) tumours in vivo. The non-uniformity of improvement was defined as the coefficient of variance of 
SNR improvement across all spectral peaks in a 2D spectrum. The error bars show the median and interquartile 
range. Results using both internal and external references are shown. Data with negative SNR improvement were 
excluded (1 dataset from a healthy volunteer using  AOCi, 1 dataset from a healthy volunteer using nd-combi, 
and 1 dataset from a tumour in vivo using nd-combi).
Figure 5.  SNR improvement distribution in a 3D plane for DQF-COSY. (a) The SNR improvement obtained 
from  WSVDi is plotted at the spectral location of each peak in a 3D scatter plot. Colour maps showing the 
direction and degree of non-uniformity of SNR improvement are shown for  WSVDi for (b) tumour specimens, 
(c) healthy volunteers, (d) peritumoural adipose tissue, and (e) tumours in vivo. The dots show the location of 
diagonal and cross peaks. The colour bar shows the SNR improvement.
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improvement without the need of additional reference spectra, but also delivers consistent improvement across 
lipids with high uniformity. With improved SNR, the acquisition can be achieved at a clinically viable time of 
8 min (instead of 17 min), enabling the routine clinical assessment of lipid composition.
Methods
A total of 72 lipid composition spectra were acquired using DQF-COSY from excised human breast tumour 
specimens, healthy female volunteers and patients with breast cancer (Fig. 1a). The ex vivo study was approved 
by the North West—Greater Manchester East Research Ethics Committee (REC reference: 16/NW/0032). The 
in vivo studies were approved by the North of Scotland Research Ethics Service (REC reference: 16/NS/0077) and 
the London—Central Research Ethics Service (REC reference: 17/LO/1777). All experiments were conducted in 
accordance with the Declaration of Helsinki guidelines and all participants provided written informed consent 
prior to the study. All scans were performed on a 3 T clinical MRI scanner (Achieva TX, Philips Healthcare, Best, 
Netherlands) using a body coil for uniform transmission.
Ex vivo study. Seventeen female patients (mean age 61 years, age range 42–78 years) with invasive carci-
noma (eight grade II and nine grade III), without prior hormonal therapy or chemotherapy and a tumour size 
greater than 10 mm in diameter were enrolled. The freshly excised whole tumour at surgery was immediately 
scanned before formalin treatment using a 32-element phased-array receiver coil for signal detection. Clinical 
standard  T1-weighted and  T2-weighted anatomical images were acquired for voxel localisation. 2D spectra of 
lipid composition were acquired using DQF-COSY8 with repetition time (TR) of 552 ms, initial echo time (TE) 
of 25 ms, a  t1 increment of 1 ms, 256 increments (mixing encoding  t1 time domain axis,  F1 frequency domain 
axis), 256 sampling points (reading encoding  t2 time domain axis,  F2 frequency domain axis), 4 repeats per incre-
ment, spectral bandwidth of 1000 Hz, and DQF gradients of 30/40/100 ms mT/m. Reference spectra without 
water suppression were acquired using single voxel PRESS  sequence26 with TR/TE of 1250/144 ms, 1024 data 
points, spectral bandwidth of 2000 Hz and 16 averages. The voxel was positioned to cover the whole tumour, 
with a voxel volume ranging from 2.7 to 16.5  cm3 according to tumour size.
In vivo study. Fifteen healthy female volunteers (mean age 66 years, age range 58–76 years) without previous 
breast cancer or family history of breast cancer participated in the study. Fifteen patients (mean age 63 years, 
age range 53–71 years, seven grade II and eight grade III) and a further ten patients (mean age 52 years, age 
range 36–63 years, one grade II and nine grade III) with invasive carcinoma were enrolled into the study for 
the acquisition of lipid composition spectra from peritumoural adipose tissue and tumour respectively. Patients 
with a tumour size greater than 10 mm, without prior chemotherapy or hormonal therapy, and no conditions 
contraindicative to MRS were eligible. All participants were scanned in the prone position as clinical routine 
practice using a 16-element phased-array breast receiver coil for signal detection. Standard sagittal  T1-weighted 
anatomical images, axial  T2-weighted anatomical images and diffusion weighted images were acquired for voxel 
localisation. 2D spectra of lipid composition were acquired using DQF-COSY8 with TR of 552 ms, initial TE of 
25 ms, a  t1 increment of 1 ms, 256 increments (mixing encoding  t1 time domain axis,  F1 frequency domain axis), 
256 sampling points (reading encoding  t2 time domain axis,  F2 frequency domain axis), 2 repeats per increment, 
spectral bandwidth of 1000 Hz, and DQF gradients of 30/40/100 ms mT/m. Reference spectra without water 
suppression were acquired using single voxel PRESS  sequence26 with TR/TE of 1250/144 ms, 1024 data points, 
spectral bandwidth of 2000 Hz and 16 averages. In healthy volunteers, data were acquired from both breasts and 
the voxel size was set to 2 × 2 × 2  cm3 containing primarily the adipose tissue. In patients, the voxel covering the 
tumour had a volume ranging from 2.2 to 21  cm3 for tumours in vivo (10 patients), while a voxel of 2 × 2 × 2  cm3 
was positioned at 1 cm from the tumour for peritumoural adipose tissue (15 patients).
Data processing. All the algorithms were developed in MATLAB (MathWorks, Natick, MA, USA) with 
the processing flowchart shown in Fig. 1b. The raw data were averaged across repeated acquisitions before signal 
combination. The averaged signal, organised as a 2D map based on  t1 and  t2 time domain axes for each coil ele-
ment, was subsequently apodised using squared sine bell along both time domain axes and zero filled to 512 × 
512 points. The reference spectrum without water suppression was used as external reference with the maximum 
peak (either water or lipid) as target  metabolite17 while the first  t1 increment of the DQF-COSY acquisition was 
used as internal reference with the maximum peak in frequency domain (either residual water or lipid) as the 
target metabolite. Both external (denoted by subscript “e”) and internal (denoted by subscript “i”) weighting 
coefficients, containing weights and phase, were computed using external and internal references respectively 
for each dataset and for each algorithm. The weighting coefficient derived for a coil element was applied to the 
apodised and zero filled signals at the corresponding coil element. The combined 2D time domain signal was 
the summation across all the coil elements, and the combined 2D spectrum was subsequently derived using 2D 
Fast Fourier transform.
The SNR of a spectral peak (Table 2) was computed as the peak height in the magnitude spectral map divided 
by the standard deviation of the real part of the noise in the square region covering  (F1: 6.9–8.4,  F2: 6.0–7.5) 
 ppm27, with the overall SNR quantified at (1.3, 1.3) ppm and SNR improvement referenced to Equal Weighting 
 algorithm27. The non-uniformity of SNR improvement across the 2D spectrum was subsequently derived as the 
coefficient of variance (standard deviation divided by the mean) of the SNR improvement across all the spectral 
 peaks19. A 3D scatter plot of SNR improvement at the spectral location of the peak was then created (Fig. 5a). A 
plane was subsequently regressed onto the 3D scatter plot to derive the direction and degree of bias in frequency 
along the diagonal (low at (0.9, 0.9) ppm to high at (5.3, 5.3) ppm) and in encoding along the off diagonal (read-
ing  t2/F2 at (0.9, 5.3) ppm to mixing  t1/F1 at (5.3, 0.9) ppm).
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Statistical analysis. Statistical analysis was performed in SPSS (Release 24.0, SPSS Inc., Chicago, USA). 
Shapiro–Wilk test was performed on the SNR and non-uniformity to assess if the distribution was normal. The 
SNR across noise decorrelated algorithms was compared using a one-way ANOVA with repeated measures and 
a Wilcoxon signed-rank test for normally and non-normally distributed data respectively. The SNR of the linear 
algorithms was also reported for reference purposes. Data with negative SNR improvement for the calculation of 
the non-uniformity were excluded (1 healthy volunteer using  AOCi, 1 healthy volunteer using nd-combi, and 1 
tumour in vivo using nd-combi). A p-value < 0.05 was considered statistically significant.
Data availability
The datasets generated during and/or analysed during the current study are available from the corresponding 
author on reasonable request.
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